KemPharm Inc. (KMPH): KMPH...$10.10...added $9.41 this in the...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

KemPharm Inc. (KMPH)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	2094
Posts	90104
Boards Moderated	0
Alias Born	12/17/2011

Re: None

Friday, 03/05/2021 8:46:04 AM

Friday, March 05, 2021 8:46:04 AM

KMPH...$10.10...added $9.41 this in the P.M....to my $10.88s...:party:
[8:42 AM]
Buy 1,000 Shares Limit $9.41 Pre-Market Only 7:15 AM 03/05/2021
Bought 600 $9.41 Settles 03/09/2021 7:16 AM 03/05/2021
Bought 8 $9.41 Settles 03/09/2021 7:16 AM 03/05/2021
Bought 69 $9.41 Settles 03/09/2021 7:16 AM 03/05/2021
Bought 20 $9.41 Settles 03/09/2021 7:20 AM 03/05/2021
Bought 300 $9.41 Settles 03/09/2021 7:20 AM 03/05/2021
Bought 3 $9.41 Settles 03/09/2021 7:21 AM 03/05/2021
CLOSEDFilledReinvest Dividends: View/Edit Order #: 62139182

Don't Criticize What You Don't Understand...

Bob Dylan...Blowin in the Wind...

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent KMPH News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2024 11:49:38 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/10/2024 08:23:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2024 11:46:20 AM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/09/2024 04:15:27 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/03/2024 08:17:44 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2024 08:15:21 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/01/2024 09:27:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 08:14:13 PM

More KMPH News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow